Delivery Order N6817123D2003-N6817124F2005
Award Date
10/24/23
Potential Completion Date
1/26/24
Potential Value
$7K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Naval Supply Systems Command
Awardee
Immucor Italia S.P.A.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Italy
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Health Agency (DHA) awarded a firm fixed-price delivery order contract to Immucor Italia S.P.A., a for-profit organization, for the provision of PANOSCREEN I, II, and III medical screening equipment. The contract, valued at $12,248.86, has an ultimate completion date of December 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) awarded to Immucor Italia S.P.A. on June 13, 2023, with a ceiling value of $138,594.60 and an ultimate completion date of...
<p>This is a Firm Fixed Price delivery order contract awarded by the Defense Health Agency to Immucor Italia S.P.A., a for-profit organization, for the PANOSCREEN I, II, and III products. The contract has a potential value of $7,639.72 and a completion date of October 27, 2023. The contract is not associated with a set-aside program.</p>
This firm fixed-price federal contract award to Immucor Inc. is for the provision of in-vitro diagnostic substances and related manufacturing services. The $20,000.00 contract was issued by the Defense Health Agency (DHA), a component of the Department of Defense, and has an ultimate completion date of September 30, 2022. The award does not have a set-aside designation. Immucor Inc. is a for-profit manufacturer specializing in automated blood testing equipment, reagents, and consumables for...
This is a firm-fixed price purchase order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostics, reagents, and blood banking supplies. The $514,572.15 contract is for the delivery of unspecified supplies, with a period of performance ending on September 30, 2023. No set-aside designation was used. Immucor is an experienced federal contractor, having previously provided a variety of medical products and services to agencies such as the...
This contract award to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products, is for the delivery of blood reagents, test kits, and diagnostic products to support the testing programs and healthcare services of the Defense Health Agency (DHA). The $260,536.03 firm fixed-price delivery order was issued under Immucor's existing General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and test kits. The award does not have a...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer, for the delivery of medical supplies such as fetal blood screen kits, blood cells, and PanoCell products. The potential value of the contract is $216,898.69, with a performance period through April 24, 2023. The contract does not have a set-aside designation. Immucor has previously been awarded federal contracts to provide blood banking supplies, reagents, and testing...
This is a Delivery Order contract awarded to Immucor Inc., a manufacturer of in vitro diagnostic reagents, test kits, and blood banking equipment. The contract was awarded by the Defense Health Agency (DHA) for $227,628.11 and has a period of performance ending on September 30, 2021. The contract is not designated as a set-aside. Immucor provides specialized reagents, blood analyzers, and related consumables to enable blood typing, compatibility testing, antibody screening, and critical blood...
This is a federal contract award to Diatec - S.R.L., an Italian for-profit company, by the Defense Health Agency (DHA). The contract, valued at $6,693.77, is a delivery order placed under two Indefinite Delivery Vehicle (IDV) contracts held by Diatec with DHA. The first IDV, contract N6817123D2002, is a single-award IDV specifically for reagents compatible with Vitros 5600 or XT7600 diagnostic systems, with a ceiling value of $223,390.14 and a period of performance through May 16, 2025. The...
Immucor Inc. was awarded a firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency (DHA) to provide rapid screen, complement control cells, Panocell, and Immucor reagents. The contract has a potential value of $20,000 and requires delivery to Fort Belvoir, Virginia by November 9, 2021. No set-aside designation was used for this award made under an existing BPA. The reagents will support DHA's medical laboratory testing programs. Immucor will serve as the...
This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Immucor Inc., a provider of automated blood testing equipment and consumables. The contract, valued at $27,702.24, is for the lease and support of the NEO IRIS blood analyzer system to support the DHA's laboratory transfusion service. This award references a previous contract (FA301620P0017) and is intended to bridge the time period until the DHA can complete their acquisition process for this equipment....